Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate
Go back to Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.39 +0.03 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.36 | 52 Week High | $4.76 | |||
| Open | $2.36 | 52 Week Low | $1.46 | |||
| Day High | $2.43 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $-1.91 | |||
| Volume | 173,514 | |||||
